Full-Time

IT Senior Delivery Manager

Enterprise Systems

Posted on 5/9/2026

LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

No salary listed

Durham, NC, USA + 1 more

More locations: Burlington, NC, USA

Hybrid

Hybrid: minimum three in-office days per week at Burlington or Durham locations; must reside within 35 miles of either location.

Category
IT & Security (1)
Required Skills
Microsoft Azure
Agile
JIRA
Risk Management
Confluence
Requirements
  • Bachelor's Degree
  • 8 or more years of experience in IT project delivery, Agile project management, or a related delivery role
  • 5 or more years of experience managing projects using both Agile and traditional PM methodologies
  • 2 or more years of experience with Jira, Confluence, Azure DevOps, or similar tools
Responsibilities
  • Manage end to end project delivery of IT initiatives (operational and transformational), ensuring scope, schedule, and quality targets are met
  • Develop project plans including scope definition, detailed activities, schedule baselines, resource plans, and cost estimates
  • Drive Agile ceremonies—sprint planning, backlog refinement, daily standups, reviews, and retrospectives—while integrating structured project controls where applicable
  • Track project performance through KPIs, sprint metrics, burndown charts, schedule variance, effort tracking, and quality indicators
  • Use AI powered tools to enhance planning accuracy, automate documentation, identify risks, and generate project insights and dashboards
  • Monitor project progress, adjust plans as needed, and ensure timely escalation of risks, issues, and dependencies
  • Maintain RAID logs and execute proactive mitigation strategies across workstreams
  • Facilitate cross functional collaboration with engineering, QA, architecture, data, and business teams to ensure project alignment and release readiness
  • Prepare and deliver clear, concise status reports, dashboards, and executive summaries for stakeholders
  • Partner with Product Owners to refine backlog priorities and ensure user stories and acceptance criteria are clear and actionable
  • Ensure adherence to governance processes, change control procedures, and compliance standards
  • Conduct stakeholder communication and management, ensuring expectations, scope, and timelines remain aligned
  • Support team productivity by leveraging generative AI for documentation, requirement drafting, summarization, and workflow automation
  • Coordinate resource allocation and collaborate with leads to manage team capacity and competency needs
  • Facilitate post implementation reviews, lessons learned, and continuous improvement activities
  • Promote a delivery culture focused on predictability, accountability, and customer centric outcomes
Desired Qualifications
  • PMP, CAPM, CSM, or SAFe certification
  • 1 or more years of experience working on CRM, analytics, cloud, or enterprise platform projects
  • 1 or more years of exposure to generative AI, project intelligence platforms, or AI driven automation tools
  • Proficiency in project planning, scheduling, risk management, and performance tracking
  • Strong understanding of AI enabled tools used in project delivery, reporting, or productivity workflows
  • Experience with cross functional delivery involving engineering, QA, architecture, and data teams
  • Familiarity with data driven reporting, KPI frameworks, and dashboarding tools
  • Excellent communication and stakeholder management skills across technical and business audiences
  • Ability to manage multiple priorities in a dynamic environment

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at LabCorp who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?